Myriad Genetics Delivers 6% Sequential Revenue Growth; Company Continues to Execute Strategic Transformation Plan
Go back to Myriad Genetics Delivers 6% Sequential Revenue Growth; Company Continues to Execute Strategic Transformation Plan| Myriad Genetics, Inc. (NASDAQ: MYGN) | Delayed: 17.98 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $17.98 | 52 Week High | $45.34 | |||
| Open | $17.98 | 52 Week Low | $15.92 | |||
| Day High | $17.98 | P/E | 7.72 | |||
| Day Low | $17.98 | EPS | $2.33 | |||
| Volume | 507 | |||||
